Alpha DNA Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,947
| Closed | -$792K | – | 249 |
|
|
2023
Q4 | $792K | Buy |
+1,947
| New | +$792K | 0.31% | 67 |
|
|
2023
Q1 | – | Sell |
-4,615
| Closed | -$1.33M | – | 204 |
|
|
2022
Q4 | $1.33M | Buy |
+4,615
| New | +$1.33M | 0.47% | 51 |
|
|
2021
Q2 | – | Sell |
-252
| Closed | -$54K | – | 644 |
|
|
2021
Q1 | $54K | Sell |
252
-19
| -7% | -$4.07K | 0.06% | 162 |
|
|
2020
Q4 | $64K | Buy |
+271
| New | +$64K | 0.07% | 151 |
|